Direct medical cost of overweight and obesity in the USA: a quantitative systematic review
- PMID: 20059703
- PMCID: PMC2891924
- DOI: 10.1111/j.1467-789X.2009.00708.x
Direct medical cost of overweight and obesity in the USA: a quantitative systematic review
Abstract
To estimate per-person and aggregate direct medical costs of overweight and obesity and to examine the effect of study design factors. PubMed (1968-2009), EconLit (1969-2009) and Business Source Premier (1995-2009) were searched for original studies. Results were standardized to compute the incremental cost per overweight person and per obese person, and to compute the national aggregate cost. A total of 33 US studies met review criteria. Among the four highest-quality studies, the 2008 per-person direct medical cost of overweight was $266 and of obesity was $1723. The aggregate national cost of overweight and obesity combined was $113.9 billion. Study design factors that affected cost estimates included use of national samples vs. more selected populations, age groups examined, inclusion of all medical costs vs. obesity-related costs only, and body mass index cut-offs for defining overweight and obesity. Depending on the source of total national healthcare expenditures used, the direct medical cost of overweight and obesity combined is approximately 5.0% to 10% of US healthcare spending. Future studies should include nationally representative samples, evaluate adults of all ages, report all medical costs and use standard body mass index cut-offs.
© 2010 The Authors. obesity reviews © 2010 International Association for the Study of Obesity.
Conflict of interest statement
Conflict of interest
Similar articles
-
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280. Health Technol Assess. 2006. PMID: 16904047
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.Health Technol Assess. 2012;16(5):iii-xiv, 1-195. doi: 10.3310/hta16050. Health Technol Assess. 2012. PMID: 22340890 Free PMC article.
-
Hormonal contraceptives for contraception in overweight or obese women.Cochrane Database Syst Rev. 2016 Aug 18;2016(8):CD008452. doi: 10.1002/14651858.CD008452.pub4. Cochrane Database Syst Rev. 2016. PMID: 27537097 Free PMC article.
-
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2. Cochrane Database Syst Rev. 2018. PMID: 30039871 Free PMC article.
Cited by
-
Income Inequality, Race/Ethnicity, and Obesity in U.S. Men 20 Years and Older: 1999 to 2016.Am J Mens Health. 2022 Sep-Oct;16(5):15579883221123852. doi: 10.1177/15579883221123852. Am J Mens Health. 2022. PMID: 36305637 Free PMC article.
-
Ageism Amplifies Cost and Prevalence of Health Conditions.Gerontologist. 2020 Jan 24;60(1):174-181. doi: 10.1093/geront/gny131. Gerontologist. 2020. PMID: 30423119 Free PMC article.
-
Sociodemographic characteristics of patients and their use of post-bariatric contouring surgery in the US.BMC Health Serv Res. 2022 Mar 7;22(1):308. doi: 10.1186/s12913-022-07692-1. BMC Health Serv Res. 2022. PMID: 35255893 Free PMC article.
-
Development of an investment case for obesity prevention and control: perspectives on methodological advancement and evidence.Rev Panam Salud Publica. 2018 Jun 6;42:e62. doi: 10.26633/RPSP.2018.62. eCollection 2018. Rev Panam Salud Publica. 2018. PMID: 31093090 Free PMC article. Review.
-
Cost of behavioral weight loss programs implemented in clinical practice: The POWER trial at Johns Hopkins.Transl Behav Med. 2020 Feb 3;10(1):103-113. doi: 10.1093/tbm/iby120. Transl Behav Med. 2020. PMID: 30855082 Free PMC article. Clinical Trial.
References
-
- Wang Y, Beydoun MA. The obesity epidemic in the United States - gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiologic Reviews. 2007;29:6–28. - PubMed
-
- Roux L, Donaldson C. Economics and obesity: costing the problem or evaluating solutions? Obes Res. 2004;12:173–179. - PubMed
-
- Williamson DF, Narayan KM, Teutsch SM. The economic impact of obesity in the United States: whither? Obes Res. 1998;6:173–175. - PubMed
-
- American Diabetes Association. Economic costs of diabetes in the U.S. Diabetes Care. 2007;31:1–20.
-
- Centers for Disease Control and Prevention. Preventing heart disease and stroke. [July 18, 2007]. Accessed at http://www.cdc.gov/nccdphp/publications/factsheets/Prevention/cvh.htm on .
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous